A library-selected, langerhans cell-targeting peptide enhances an immune response

DNA and Cell Biology

Volumn 23, Issue 11, 2004, Pages 742-752

  McGuire, Michael J ^a   Sykes, Kathryn F ^a,f   Samli, Kausar N ^a   Timares, Laura ^a,d   Barry, Michael A ^a,e   Stemke Hale, Katherine ^a,f   Tagliaferri, Frank ^c   Logan, Mark ^c   Jansa, Kimberly ^c   Takashima, Akira ^a,b   Brown, Kathlynn C ^a   Johnston, Stephen Albert ^a,g  

^a Department of Internal Medicine   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Urigen Pharmaceuticals Inc   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e CENTER FOR CELL AND GENE THERAPY   (United States)

^f MacroGenics Inc   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; LIPOSOME; NANOPARTICLE; PEPTIDE DERIVATIVE;

ANIMAL CELL; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENERGY YIELD; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOGENETICS; IN VITRO STUDY; INJECTION; INTERMETHOD COMPARISON; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 4143067588     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2004.23.742     Document Type: Article

References (47)

1. AKERMAN, M.E., CHAN, W.C., LAAKKONEN, P., BHATIA, S.N., and RUOSLAHTI, E. (2002). Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA 99, 12617-12621.
2. ARAP, W., PASQUALINI, R., and RUOSLAHTI, E. (1998). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279, 377-380.
3. BANCHEREAU, J., BRIERE, F., CAUX, C., DAVOUST, J., LEBECQUE, S., LIU, Y.J., PULENDRAN, B., and PALUCKA, K. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
4. BARANY, G., KNEIB-CORDONIER, N., and MULLEN, D.G. (1987). Solid-phase peptide synthesis: A silver anniversary report. Int. J. Peptide Protein Res. 30, 705-739.
5. BARRY, M.A., DOWER, W.J., and JOHNSTON, S.A. (1996). Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med. 2, 299-305.
6. BERRY, J.D., LICEA, A., POPKOV, M., CORTEZ, X., FULLER, R., ELIA, M., KERWIN, L., KUBITZ, D., and BABAS, C.F. (2003). Rapid monoclonal antibody generation via dendritic cell targeting in vivo. Hybrid Hybridom. 22, 23-31.
7. BROWN, K.C. (2000). New approaches for cell-specific targeting: Identification of cell-selective peptides from combinatorial libraries. Cuur. Opin. Chem. Biol. 4, 16-21.
8. CARAYANNIOTIS, G., SKEA, D.L., LUSCHER, M.A., and BARBER, B.H. (1991). Adjuvant-independent immunization by immunotargeting antigens to MHC and non-MHC determinants in vivo. Mol. Immunolog. 28, 261-267.
9. CAUX, C., DEZUTTER-DAMBUYANT, C., SCHMITT, D., and BANCHEREAU, J. (1992). GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360, 258-261.
10. CELLA, M., SALLUSTO, F., and LANZAVECCHIA, A. (1997). Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9, 10-16.
11. CHAN, W.C., MAXWELL, D.J., GAO, X., BAILEY, R.E., HAN, M., and NIE, S. (2002). Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 13.
12. CONDON, C., WATKINS, S.C., CELLUZZI, C.M., THOMPSON, K., and FALO, L.D., Jr. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2, 1122-1128.
13. CWIRLA, S.E., PETERS, E.A., BARRETT, R.W., and DOWER, W.J. (1990). Peptides on phage: A vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA 87, 6378-6382.
14. DELIYANNIS, G., BOYLE, J.S., BRADY, J.L., BROWN, L.E., and LEW, A.M. (2000). A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc. Natl. Acad. Sci. USA 97, 6676-6680.
15. DIEBOLD, S.S., KURSA, P., WAGNER, E., COTTEN, M., and ZENKE, M. (1999). Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J. Biol. Chem. 274, 19087-19094.
16. FALO, L.D., Jr. (1999). Targeting the skin for genetic immunization. Proc. Assoc. Am. Phys. 111, 211-219.
17. FIELDS, R.C., SHIMIZU, K., and MULE, J.J. (1998). Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95, 9482-9487.
18. FORSSEN, E., and WILLIS, M. (1998). Ligand-targeted liposomes. Adv. Drug Deliv. Rev. 29, 249-271.
19. GLENNIE, M.J., and JOHNSON, P.W.M. (2000). Clinical trials of antibody therapy. Immunol. Today 21, 403-410.
20. GREEN, M.C., MURRAY, J.L., and HORTOBAGYI, G.N. (2000). Monoclonal antibody therapy for solid tumors. Cancer Treat. Rev. 26, 269-286.
21. HOLTL, L., RIESER, C., PAPESH, C., RAMONER, R., BARTSCH, G., and THURNHER, M. (1998). Cd83(+) blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer. Lancet 352, 1358.
22. HOLTL, L., RIESER, C., PAPESH, C., RAMONER, R., HEROLD, M., KLOCKER, H., RADMAYR, C., STENZL, A., BARTSCH, G., and THURNHER, M. (1999). Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J. Urol. 161, 777-782.
23. JIANG, W., SWIGGARD, W.J., HEUFLER, C., PENG, M., MIRZA, A., STEINMAN, R.M., and NUSSENZWEIG, M.C. (1995). The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151-155.
24. KUMAMOTO, T., MORITA, A., and TAKASHIMA, A. (2001). Recent advances in dendritic cell vaccines for cancer treatment. J. Dermatol. 28, 658-662.
25. KUMAMOTO, T., HUANG, E.K., PAEK, H.J., MORITA, A., MATSUE, H., VALENTINI, R.F., and TAKASHIMA, A. (2002). Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat. Biotechnol. 20, 64-69.
26. MACDONALD, G.H., and JOHNSTON, R.E. (2000). Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 74, 914-922.
27. MARLAND, G., BAKKER, A.B., ADEMA, G.J., and FIGDOR, C.G. (1996). Dendritic cells in immune response induction. Stem Cells 14, 501-507.
28. MATSUE, H., MATSUE, K., WALTERS, M., OKUMURA, K., YAGITA, H., and TAKASHIMA, A. (1999). Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells. Nat. Med. 5, 930-937.
29. OYAMA, T., SYKES, K.F., SAMLI, K.N., MINNA, J.D., JOHNSTON, S.A., and BROWN, K.C. (2003). Isolation of lung tumor specific peptides from a random pepitde library: generation of diagnostic and cell-targeting reagents. Cancer Lett. 202, 219-230.
30. PASQUALINI, R., and RUOSLAHTI, E. (1996). Organ targeting in vivo using phage display peptide libraries. Nature 380, 364-366.
31. PLOTKIN, S.L., and PLOTKIN, S.A. (1994). A Short History of Vaccination. (Saunders Company, Philadelphia).
32. RAJOTTE, D., ARAP, W., HAGERDORN, M., KOIVUNEN, E., PASQUALINI, R., and RUOSLAHTI, E. (1998). Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102, 430-437.
33. RODI, D.J., and MAKOWSKI, L. (1999). Phage-display technology - Finding a needle in a vast haystack. Curr. Opin. Biotechnol. 10, 87-93.
34. SALLUSTO, F., and LANZAVECCHIA, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179, 1109-1118.
35. SCHUHMACHERS, G., XU, S., BERGSTRESSER, P.R., and TAKASHIMA, A. (1995). Identity and functional properties of novel skin-derived fibroblast lines (NS series) that support the growth of epidermal-derived dendritic cell lines. J. Invest. Dermatol. 105, 225-230.
36. SHIMIZU, K., FIELDS, R.C., REDMAN, B.G., GIEDLIN, M., and MULE, J.J. (2000). Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2. Cancer J. Sci. Am. 6, S67-S75.
37. SHIMIZU, Y., GUIDOTTI, L.G., FOWLER, P., and CHISARI, F.V. (1998). Dendritic cell immunization breaks cytotoxic t lymphocyte tolerance in hepatitis b virus transgenic mice. J. Immunol. 161, 4520-4529.
38. SMITH, G.P., and PETRENKO, V.A. (1997). Phage display. Chem. Rev. 97, 391-410.
39. TAM, J.P. (1988). Synthetic peptide vaccine design: Synthesis and properties of a high density multiple antigenic system. Proc. Natl. Acad. Sci. USA 85, 5409-5413.
40. TAM, J.P. (1996). Recent advances in multiple antigen peptides. J. Immunol. Methods 196, 17-32.
41. TAM, J.P., LU, Y.A., and YANG, J.L. (2002). Antimicrobial dendrimeric peptides. Eur. J. Biochem. 269, 923-932.
42. TANG, D.C., DEVIT, M., and JOHNSTON, S.A. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152-154.
43. TIMARES, L., TAKASHIMA, A., and JOHNSTON, S.A. (1998). Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc. Natl. Acad. Sci. USA 95, 13147-13152.
44. TREPEL, M., ARAP, W., and PASQUALINI, R. (2001). Modulation of the immune response by systemic targeting of antigens to lymph nodes. Cancer Res. 61, 8110-8112.
45. TUTING, T., STORKUS, W.J., and FALO, L.D., Jr. (1998). DNA immunization targeting the skin: molecular control of adaptive immunity. J. Invest. Dermatol. 111, 183-188.
46. WANG, H., GRIFFITHS, M.N., BURTON, D.R., and GHAZAL, P. (2000). Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization. Proc. Natl. Acad. Sci. USA 97, 847-852.
47. XU, S., BERGSTRESSER, P.R., and TAKASHIMA, A. (1995). Phenotypic and functional heterogeneity among murine epidermal-derived dendritic cell clones. J. Invest. Dermatol. 105, 831-836.